Printing And Publishing Tenders

In application of the provisions of articles L 225-218 et seq., L 225-40, L 820-1 to L 823-20 and R 225-161 et seq. and R 821-1 to R 823-21. For the years 2024 to 2029

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicinal Products with the Active Ingredient Rivaroxaban (B01af01), with an Effective Strength of 2.5 Mg Per Divided Dosage Fo...
Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products with the active ingredient Rivaroxaban (B01AF01), with an effective strength of 2.5 mg per divided dosage form as part of a so-called open house model.
Conclusion non-exclusive discount agreements in accordance with Section 130a Abs. 8/130c Para. 1 SGB V on medicines with the active ingredient rivaroxaban (B01AF01), with an effective strength of 2.5 mg per divided dosage form within the period from April 1st, 2024 to March 31st, 2026 with the possibility of concluding a contract at any time (open-house Model). They are in the open house processMedicines according to the BfArM list according to Section 35 Paragraph 5a SGB V (children's medicines) excluded.
Conclusion of non-exclusive discount contracts in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicines with the active ingredient Rivaroxaban (B01AF01), in which Effectiveness 2.5 mg per divided dosage form im as part of a so-called open house model.
The AOK Rhineland-Palatinate/Saarland - The health insurance company offers all interested pharmaceutical companies, without a selection decision, discount contracts with the active ingredient rivaroxaban (B01AF01) with an effective strength of 2.5 mg per divided dosage form.The contracts are concluded as part of an "open house model". The contracts offered are not exclusive; Contracts with all market participants (pharmaceutical companies) are desired by AOK Rheinland-Pfalz/Saarland - The Health Insurance Fund. In the open house model, everyone...

soup

food waste disposer

Application for registration for Co-marketing for supply of Potassium derived from Molasses (PDM) in all states

Description
OPEN-SOURCE SOFTWARE LICENSING OPPORTUNITY
RAVEN: Comprehensive Uncertainty Quantification and Optimization for Complex Systems
RAVEN is a versatile framework designed for uncertainty quantification, risk assessment, and optimization of complex systems, integrating advanced statistical, data analysis, and AI techniques for enhanced system understanding and performance.
Overview: Developed in 2012 under the Risk Informed Safety Margin Characterization (RISMC) pathway of the Light Water Reactor Sustainability (LWRS) program, RAVEN (Risk Analysis and Virtual ENvironment) addresses the need for modern risk evaluation in complex systems like nuclear power plants. It caters to the increasing demand for sophisticated tools to analyze systems' responses under varied conditions, especially considering the uncertainties inherent in these systems. RAVEN's design philosophy aims to be user-friendly for engineers and scientists while offering a modular structure for easy expansion by developers. This balance makes RAVEN a powerful tool for a wide range of applications in different sectors.
Description: RAVEN operates by perturbing system responses using various strategies (Monte-Carlo, Latin Hypercube, etc.) and analyzing the data through classical and advanced data mining approaches. It works in tandem with other INL software (like RELAP5-3D, MAAP5, BISON) to model complex physical systems. RAVEN's strength lies in its ability to manage parallel dispatching of simulations and its use of AI algorithms to create surrogate models for complex analysis tasks. This multifaceted approach allows for thorough uncertainty quantification, reliability analysis, and parametric studies, making it a comprehensive tool for risk assessment and optimization in complex environments.
Benefits:
Versatile Analysis Capabilities: Supports various analysis methods, including regression, risk assessment, and data mining. Integration with Third-party Software: Enha...

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Rivaroxaban (B01af01), only Hard Capsules Excl. Potency 2.5Mg as Part of a So-Called...
Conclusion of non-exclusive discount contracts in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicines with the active ingredient Rivaroxaban (B01AF01), only hard capsules excl. potency 2.5mg as part of a so-called open house model.
Non-exclusive conclusion Discount contracts in accordance with Sections 130a Paragraph 8/130c Paragraph 1SGB ​​V on medicines with the active ingredient Rivaroxaban (B01AF01), only hard capsules excluding potency 2.5mg within the period from April 1st, 2024 to March 31st, 2026 with the possibility of concluding a contract at any time (open-house model). In the open house procedure, medicines are in accordance with the BfArM list according to Section 35 Paragraph 5a SGB V (children's medicines) excluded.
Conclusion of non-exclusive discount contracts in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicines with the active ingredient Rivaroxaban (B01AF01), only hard capsules excluding potency 2.5mg as part of a so-called open house model.
TheAOK Rhineland-Palatinate/Saarland - The health insurance company offers discount contracts with the active ingredient Rivaroxaban (B01AF01), only hard capsules excl. potency 2.5 mg, to all interested pharmaceutical companies without a selection decision. The contracts are concluded as part of an "open house model".The contracts offered are not exclusive; Contracts with all market participants (pharmaceutical companies) are desired by AOK Rheinland-Pfalz/Saarland - The Health Insurance Fund. In the open house model, uniform conditions apply to all participants. Contract contents, conditions...

1.The object of call for expressions of interestThis call for expressions of interest is organised on the basis of Article 237 of the Financial Regulation(1). The purpose of this call for expressions of interest is to set up a list of external experts in the domains of data visualisation, open data and semantic web for the Publications Office of the European Union. The experts will provide support in the creation of new products, services and/or tools in these domains. The following profiles are foreseen: (a) data visualisation expert: gathering of needs and business requirements, analysis and review of stakeholders- contributions, drafting specifications, preparing documentation, advice and assistance in creating visualisations and supporting the process to publish the content on the Web; (b) open data expert: working with open data, drafting open data policies, support in the lifecycle and best practices for open data; (c) semantic web expert: writing schemas, mappings, documentation, code or other artefacts to further link content and data from the EU. (1) Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council of 18 July 2018 on the financial rules applicable to the general budget of the Union, amending Regulations (EU) No 1296/2013, (EU) No 1301/2013, (EU) No 1303/2013, (EU) No 1304/2013, (EU) No 1309/2013, (EU) No 1316/2013, (EU) No 223/2014, (EU) No 283/2014, and Decision No 541/2014/EU and repealing Regulation (EU, Euratom) No 966/2012 (OJ L 1...

Tenders Are Invited 2021-OJS008-015261-enThe contracting entity, has published a contract notice in the OJEU, and the eTenders website regarding a qualification system for Offshore Wind Resource and Metocean Measurement Campaigns on sites off the coast of Ireland and the UK. The wind measurement and metocean data will be utilized to:(i) enable offshore structures to be designed against both extreme and fatigue loading conditions as observed on site;(ii) to enable installation and O and M contractors to plan onsite operations; and(iii) to inform on turbine and installation vessel selection.

Tenders Are Invited Lot 2 Offshore Metocean Measurement Campaign Lot 2 consists of the provision of meteorological and oceanographic (metocean) measurements through an onsite measurement campaign at the location of proposed offshore windfarm developments in the UK and Ireland. The main objectives of the work are to provide and analyse the following metocean data to support characterization of the metocean climate at the site: